The healthcare market is fueling digital transformation by improving efficiency and fostering personalized care, making it an ...

With Neurocrine having finally shaken up treatment for a rare genetic hormone disease, Harbour BioMed’s antibody offshoot has ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Apollon Wealth Management LLC lessened its holdings in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 3.2% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange ...

Investors in Cardinal Health, Inc. (Symbol: CAH) saw new options become available today, for the March 28th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

Healthcare distributor and services company Cardinal Health (NYSE:CAH) beat Wall Street’s revenue expectations in Q4 CY2024, but sales fell by 3.8% year on year to $55.26 billion. Its non-GAAP ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

One company to watch right now is Cardinal Health (CAH). CAH is currently sporting a Zacks Rank of #2 (Buy), as well as a Value grade of A. The stock holds a P/E ratio of 14.87, while its industry ...

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals ...